Accelerating the Development of Biologic Therapeutics through Advanced Analytics

Biologic Development Image

BioAnalytix is developing and applying advanced analytic methods and data to enable, improve and accelerate biologic therapeutics from development through market


What We Do

BioAnalytix is a pharmaceutically oriented spin-out from the Barnett Institute of Chemical and Biological Analysis at Northeastern University. Founded in 2012 by thought leaders in biologic drug development, regulatory strategy, and advanced analytics, BioAnalytix works with leading pharmaceutical companies to develop and apply advanced analytic technologies, methods and data in enabling, improving and accelerating biologic therapeutics from development through market.


Recent Scientific Case Studies

Advanced HDX-MS and Native-MS for Improved Biologic Candidate Selection and Development

LC-MS Based Host Cell Protein Analysis

Talk to Us

Whether you are looking to learn more about our platforms or get a project started, our team will be happy to connect with more information.


Latest News

BioAnalytix Collaborates with Key Pharma to Publish New Review Article: Structure, Heterogeneity and Developability Assessment of Therapeutic Antibodies

mAbs – December 2018





BioAnalytix Scientists Jointly Publish with Top Academic Institutions to Support Successful On-Demand Manufacturing of Clinical-Quality Biopharmaceuticals

Nature Biotechnology – October – 2018